Karuna Therapeutics, Inc. Profile Avatar - Palmy Investing

Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic rece…

Biotechnology
US, Boston [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

No VpE graphs at the moment.

Employee Surveys

Employees Asked: -

No survey available at the moment.

Talent Acquisition

Permanent Employees

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Karuna Therapeutics, Inc. can't present the data

Top Demand Within Q3:

Not available for Karuna Therapeutics, Inc.

Temporary Employees H1Bs

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

Karuna Therapeutics, Inc. can't present the data

Top Demand Within Q3:

    Not available for Karuna Therapeutics, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of KRTX's Analysis
CIK: 1771917 CUSIP: 48576A100 ISIN: US48576A1007 LEI: - UEI: -
Secondary Listings
KRTX has no secondary listings inside our databases.